Search Results for: TUBA4A

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel GRM7 glutamate metabotropic receptor 7
  • G alpha (i) signalling events
  • Class C/3 (Metabotropic glutamate/pheromone receptors)
  • Glutamic acid
Novel HDAC6 histone deacetylase 6
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • HSF1 activation
  • Notch-HLH transcription pathway
  • Cargo trafficking to the periciliary membrane
  • Transcriptional regulation by RUNX2
  • RUNX2 regulates osteoblast differentiation
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
  • Valproic acid
  • Decitabine
  • Vorinostat
  • Vorinostat
  • Belinostat
  • Pracinostat
  • Romidepsin
  • Romidepsin
  • Panobinostat
  • Phenylbutyric acid
  • Entinostat
  • Abexinostat
  • Givinostat
  • Pyroxamide
  • Bufexamac
Novel HPCA hippocalcin
Novel HSPH1 heat shock protein family H (Hsp110) member 1
  • Scavenging by Class F Receptors
  • Scavenging by Class F Receptors
  • Regulation of HSF1-mediated heat shock response
  • Phenethyl Isothiocyanate
Novel IL1RL1 interleukin 1 receptor like 1
  • PIP3 activates AKT signaling
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Interleukin-33 signaling
Novel LGALS2 galectin 2
  • Beta-D-Glucose
Novel LTA lymphotoxin alpha
  • TNFR2 non-canonical NF-kB pathway
  • TNFs bind their physiological receptors
  • TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
  • TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
  • Etanercept
Novel MAGED1 MAGE family member D1
  • NRAGE signals death through JNK
  • Caspase activation via Dependence Receptors in the absence of ligand
Novel MAP1A microtubule associated protein 1A
  • Estramustine
Novel MAP1LC3A microtubule associated protein 1 light chain 3 alpha
  • Macroautophagy
  • PINK1-PRKN Mediated Mitophagy
  • Receptor Mediated Mitophagy
Novel MAPT microtubule associated protein tau
  • Caspase-mediated cleavage of cytoskeletal proteins
  • Lansoprazole
  • Astemizole
  • Paclitaxel
  • Docetaxel
  • Flortaucipir F-18
  • Progressive supranuclear palsy (PSP); Steele-Richardson-Olszewski syndrome
  • Frontotemporal lobar degeneration (FTLD), including: Pick disease of brain; Frontotemporal dementia (FTD); Ubiquitin-positive frontotemporal dementia (UP-FTD); Progressive supranuclear palsy type 1 (PSNP1); Inclusion body myopathy with early-onset paget disease and frontotemporal dementia (IBMPFD); Frontotemporal dementia, chromosome 3-linked (FTD3)
  • Amyotrophic lateral sclerosis (ALS); Lou Gehrig's disease
Novel MARK4 microtubule affinity regulating kinase 4
  • Anchoring of the basal body to the plasma membrane
  • Fostamatinib
Novel MYC MYC proto-oncogene, bHLH transcription factor
  • Transcription of E2F targets under negative control by DREAM complex
  • Signaling by ALK
  • NOTCH1 Intracellular Domain Regulates Transcription
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Binding of TCF/LEF:CTNNB1 to target gene promoters
  • MAPK6/MAPK4 signaling
  • Ub-specific processing proteases
  • Interleukin-4 and Interleukin-13 signaling
  • Cyclin E associated events during G1/S transition
  • Cyclin A:Cdk2-associated events at S phase entry
  • TFAP2 (AP-2) family regulates transcription of cell cycle factors
  • RUNX3 regulates WNT signaling
  • Estrogen-dependent gene expression
  • Transcriptional regulation of granulopoiesis
  • Regulation of CDH1 mRNA translation by microRNAs
  • Regulation of NFE2L2 gene expression
  • Regulation of PD-L1(CD274) transcription
  • Acetylsalicylic acid
  • Dimethyl sulfoxide
  • Doconexent
  • Nadroparin
  • Penile cancer
  • Breast cancer
  • Laryngeal cancer
  • Oral cancer
  • Multiple myeloma
  • Kaposi's sarcoma
  • Ovarian cancer
  • Choriocarcinoma
  • Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)
  • Burkitt lymphoma
  • Small cell lung cancer
  • Osteosarcoma
  • Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
Novel NCALD neurocalcin delta
  • Activation of Ca-permeable Kainate Receptor
Novel NUPR1 nuclear protein 1, transcriptional regulator
Novel OGT O-linked N-acetylglucosamine (GlcNAc) transferase
  • HATs acetylate histones
  • RIPK1-mediated regulated necrosis
  • Regulation of necroptotic cell death
  • UCH proteinases
  • Formation of WDR5-containing histone-modifying complexes
Novel PFDN4 prefoldin subunit 4
  • Prefoldin mediated transfer of substrate to CCT/TriC
Novel PLK1 polo like kinase 1
  • Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
  • Polo-like kinase mediated events
  • Golgi Cisternae Pericentriolar Stack Reorganization
  • Golgi Cisternae Pericentriolar Stack Reorganization
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Phosphorylation of the APC/C
  • Phosphorylation of Emi1
  • Condensation of Prophase Chromosomes
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • Regulation of PLK1 Activity at G2/M Transition
  • Activation of NIMA Kinases NEK9, NEK6, NEK7
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • RHO GTPases Activate Formins
  • Mitotic Prometaphase
  • Mitotic Metaphase/Anaphase Transition
  • Mitotic Telophase/Cytokinesis
  • Cyclin A/B1/B2 associated events during G2/M transition
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • AURKA Activation by TPX2
  • EML4 and NUDC in mitotic spindle formation
  • Regulation of MITF-M-dependent genes involved in cell cycle and proliferation
  • 3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol
  • 3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide
  • 4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE
  • 1-[5-Methyl-2-(trifluoromethyl)furan-3-yl]-3-[5-[2-[[6-(1H-1,2,4-triazol-5-ylamino)pyrimidin-4-yl]amino]ethyl]-1,3-thiazol-2-yl]urea
  • Wortmannin
  • Fostamatinib
  • Volasertib
Novel PRKN parkin RBR E3 ubiquitin protein ligase
  • PINK1-PRKN Mediated Mitophagy
  • Regulation of necroptotic cell death
  • Josephin domain DUBs
  • Aggrephagy
  • Amyloid fiber formation
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Parkinson's disease (PD)
Novel RAB8B RAB8B, member RAS oncogene family
  • TBC/RABGAPs
  • RAB geranylgeranylation
  • RAB GEFs exchange GTP for GDP on RABs
  • Phosphoaminophosphonic acid guanylate ester
  • Guanosine-5'-Diphosphate

Page 2 out of 7 pages